Updated: GSK and Flagship to create up to 10 vaccines, medicines across respiratory and immunology
GSK and Flagship Pioneering will jointly pay up to $150 million to kick-start a respiratory and immunology tie-up.
The pair will create new vaccines and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
